SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000200406-24-000043
Filing Date
2024-04-29
Accepted
2024-04-29 16:32:50
Documents
15
Period of Report
2024-04-25
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K jnj-20240425.htm   iXBRL 8-K 71049
2 EX-3.1 a2024bylawsamendments-clea.htm EX-3.1 158074
  Complete submission text file 0000200406-24-000043.txt   451050

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jnj-20240425.xsd EX-101.SCH 3328
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jnj-20240425_def.xml EX-101.DEF 17201
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jnj-20240425_lab.xml EX-101.LAB 31770
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jnj-20240425_pre.xml EX-101.PRE 18108
18 EXTRACTED XBRL INSTANCE DOCUMENT jnj-20240425_htm.xml XML 6319
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Filer) CIK: 0000200406 (see all company filings)

IRS No.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 1229
Type: 8-K | Act: 34 | File No.: 001-03215 | Film No.: 24891540
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)